Prior Authorization Changes for Some Commercial and Government Program Members
Summary
Blue Cross Blue Shield of Texas is restructuring prior authorization requirements for commercial, Medicare Advantage, and Medicaid members effective October 1, 2026 and January 1, 2027. Changes include shifting specific procedure codes (medical oncology drugs, genetic testing, orthotics, wound care, DME, neurostimulator sleep services) between utilization management vendors (Carelon, BCBSTX, EviCore) and removing the 'Recommended Clinical Review' option by end of 2027. Billing teams must verify current prior authorization requirements through Availity before rendering services, as prior auth vendor assignments and requirements are changing significantly.
Get alerts when payers change rules like this one
We check BCBS Texas and other payers every day and email you when a change matches your specialty and state.